πŸ‡ΊπŸ‡Έ FDA
Patent

US 11932606

Anti-cancer/anti-fibrosis compounds

granted A61KA61K31/473A61P

Quick answer

US patent 11932606 (Anti-cancer/anti-fibrosis compounds) held by The Regents of the University of California expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/473, A61P, A61P35/00